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Abstract:
Background:
Selegiline is used to treat Parkinsonian patients. Other indications of its use have recently been discovered.
Objective:
Scouting special and beneficial side effects of selegiline treatment.
Method:
Two-year old male Wistar rats were daily treated with 0.25 mg/kg of selegiline s.c. (subcutaneous injection). The rats were sacrificed
following a four-weeks’ treatment.
Results:
Mass of testes, number of sperms, progressive motility of sperms, and their viability definitely increased.
Conclusion:
Selegiline can successfully be used to stop/counterbalance certain symptoms of aging.
Keywords: Selegiline, Aged-rats, Semen, Dopamine, Testis, Sperm, Testosterone, Cortisol.
1. INTRODUCTION
Ecsery et al [1] were the first to describe the synthesis of racemic E250 (deprenyl) in 1962, while its levorotatory
form (L-deprenyl or (-)-deprenyl, selegiline) was prepared shortly afterwards [2]. Pharmacology of selegiline indicated
its psychic energizer effect [3].
Peculiar pharmacological characteristics of selegiline  (L-deprenyl, also  called: Anipryl,  Carbex, Emsam,  Humex,
Jumex, Yumex, etc.)  were discovered  by Knoll  and Magyar  [4], was  proven  as  the  first  specific  and  selective
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monoamine oxidase B inhibitor [4, 5]. Selegiline has been used in clinical practice all over the world for the treatment
of patients having Parkinsonism [5, 6].
The original indication of selegiline has had its renaissan. Gordon et al [7] carried out their classical experiments on
rats. Transdermal selegiline was successfully used in a double-blind and placebo-controlled study in hospital outpatients
having major depression [8, 9].
Knoll [10] and Knoll et al [11] experimentally detected relationship between sexual behavior and longevity using
both male and female rats.
Preliminary pharmacological  experiments  aimed at  the  use  of  selegiline  in  the  possible  improvement  of  human
reproduction power. The initial process of reproduction (coitus or sexual intercourse) in some mammalian organisms
contain two steps. One of them is when a male approaches a female, they copulate so that the sperms of the male enters
the sexual organ of the female. Dalló [12], Dalló and Held [13, 14] made up and carried out the first experiments on
how to influence sexual behavior of rats using drugs. Knoll, Dalló and others performed in vivo experiments on rats to
show individual differences in sexual activity and also how it can be improved by treatments with selegiline [15 - 23].
Dalló  et  al  [18]  carried  out  their  experiments  using  more  than  200  male  rats,  and  found  aphrodisiac  effects  when
treating the rats with 0.25 mg/kg of selegiline. The aphrodisiac effect could be observed in sexually sluggish or non-
copulatory male rats [17]. Knoll concluded that improvement in sexual activity was produced in the process of a special
activation of the dopaminergic system. Both the copulation process and the quality/degree of copulation mainly depend
on sexual performance of male rats that can be either sexually inactive (that is “low-performing”) or highly active (that
is high-performing). In the case of young adult male rats, Knoll [18, 24] deduced sexual performance from the level of
the basic activity of catecholaminerg neurons, especially releasing dopamine in the tuberculum olfactorium,  corpus
striatum  and substantia nigra  in the state of resting [18]. Selegiline, which stimulates dopamine release on the one
hand, on the other hand, mainly saves the released dopamine from degradation by the monoamine oxidase enzyme.
Knoll, Dalló and co. [10 - 24] classified male rats based on their copulatory behavior. Certain (1) sexually inactive
male  rats  did  not  show  any  intention  to  mate  sexually  receptive  female  rats,  (2)  other  male  rats  show  solely
intermissions (without ejaculation), (3) sexually sluggish male rats show at least one intermission without ejaculation,
while  sexually  active  male  rats  achieve  complete  sexual  activity  including  intermissions  and  ejaculations.  The
intermission  capacity  of  rats  did  not  decrease  significantly,  however,  the  ejaculation  ability  of  about  50% of  these
subjects  decreased  after  5  to  24  weeks,  and  practically  stopped  thereafter.  By  the  treatment  of  male  rats  with  s.c.
injection of 0.25 mg/kg of selegiline for 20 weeks, their ejaculation ability was restored. Life span of both male and
female rats was significantly increased. The average life span of the treated 66 male rats was 191 weeks, while that of
the  controls  was  147  weeks.  Similar  results  were  obtained  in  the  case  of  ovariectomized  female  rats  treated  with
selegiline  for  25.1  weeks  versus  13.17  weeks’  treatment  of  the  controls.  Concerning  intact  (non-subjected  to
ovariectomy)  female  rats,  they  did  not  show  any  difference  whether  they  were  treated  with  selegiline  or  with
physiological  salt  solution  or  not.
Another essentially important factor of reproduction is the entire quality of sperms that is the number of sperms,
their progressive motility and viability (ratio of live versus dead sperms).
Clinical observations by Urry et al [25, 26] showed coincidence between low testosterone levels and definitely low
sperm concentration. Urry et al [27] found that pargyline treatment had an age-related effect on the reproductive organs
of male rats.
In vitro effects of caffeine and theophylline on human semen quality were tested by Dougherty et al [28] from 10-2
through 10-6 M concentrations without any change in sperm motility and viability of sperms.
Recent publications by Mihalik et al [29 - 31] treat the effect of selegiline on male sperms and the testes.
Tekes et al gave the first direct proof of penetration of selegiline into the testes of rats [32]. Following 15, 60 and
180 minutes of intraperitoneal administration of a relatively high dose of selegiline (15 mg/kg), its level in the testis was
similar to those in serum. At the same time, the level of selegiline in the brain was higher than either in the serum, CSF
(cerebrospinal fluid) or testis. The incorporation of selegiline in the brain can clearly be seen in the pictures of whole-
body autoradiography taken 15 and 60 minutes following i.p. administration of radiolabeled selegiline, as well as the
determination of selegiline levels using reversed-phase HPLC [32].
Similar results were found when using a rabbit model [33]. The selegiline level was similar or higher in the testes
than in the brain at least 30 minutes following intravenous injection.
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Zieher et al [34] determined a definite decline (down to about 1%) of the level of several biogenic amines through
120 days of their lives in the rats’ testes. The concentration of dopamine decreased from 22.16 µg/g to 0.174 µg/g). The
determinations were done using the fluorimetric method of Carlsson and Waldeck [35],
Contrary  to  the  effect  of  selegiline  on  the  physical/copulatory  activity  of  rats  and  on  the  brain’s  dopamine
concentration, the concentration of deprenyl in the testes did not show any definite increase following a four-weeks’
treatment using selegiline in aged rats.
This  paper  is  meant  to  show  how  selegiline  treatment  influences  the  “quality”  of  sperms  following  chronic
treatments  with  their  usual  therapeutic  dose.
2. MATERIALS AND METHODS
2.1. Materials
Selegiline (Fig. 1) was the kind gift of Chinoin Chemical and Pharmaceutical Works(Budapest); its present name is
Sanofi-Aventis/Chinoin (Budapest, Hungary).
Fig. (1). The chemical structure of selegiline.
2.2. Animals
Male Hanover Wistar rats of two years of age were supplied by Toxicoop (Budapest, Hungary).
2.3. Methods
2.3.1. Treatments of Rats
Ten rats (five treated and five controls) were o.c. treated with a 0.25 mg/kg daily dose of selegiline for four weeks.
Treatments  were  performed  according  to  the  experimental  protocol  approved  by  ethical  committee  of  ANTSZ
(Budapest,  Hungary),  permission  number:  1810/03/2004.  The  experimental  conditions  conformed  to  86/509  EEC
(European Economic Community) regulation. The control group received only the physiological salt solution.
2.3.2. Preparation of Tissue for the Analysis of Sperm Motility and Morphology
The  testes  and  epididymes  were  removed  and  the  cauda  epididymes  were  ligated  at  autopsy  and  kept  in  PBS
(Phosphate-Buffered Saline) until semen evaluation. Following the separation of the complete epididymis, the testicles
were weighed. The epididymes were placed in Petri dishes containing 0.5 mL PBS with 10 mg/mL of BSA (Bovine
Serum Albumin). Cauda epididymes were minced with iridectomy scissors, by five deep cuts. The Petri dishes were
covered and incubated at 37 °C for 10 minutes. Prior to the assessment of sperm motility, 10 µL of supernatant was
dropped at the prewarmed slides and covered with a lid. The sample was held at 37 °C while the velocity parameters,
including the progressive motility of minimum 100 sperms at 10 fields, were observed. Progressive sperm motility was
evaluated using the standard method of Bearden and Fuquay [36]. The mean of the ten estimations was used as the final
motility score.
The total sperm number was determined by using a hemocytometer. Approximately, 10 µL of the diluted semen was
added to 390 µL of Hank’s Balanced Formaldehyde Solution. Ten microliters of semen, fixed in formaldehyde were
transferred  to  the  counting  chamber  of  the  hemocytometer  and  the  cells  were  counted  with  the  help  of  a  light
microscope (200x). The sperm cell number of ten large squares multiplied by the dilution rate gave the original sperm
cell count.
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Sperm cell  morphology  was  evaluated  by  stain  of  Eosin-Nigrosine  and  Spermac  Stain  at  a  400x  magnification
(FertiPro N.V., Beernem, Belgium) as it is prescribed [36].
2.3.3. Tissue Homogenization and Hormone Concentration
Small  pieces  of  each  testicle  and  adrenal  gland  were  precisely  weighed  by  analytical  scales.  The  pieces  were
homogenized with PBS by a tissue homogenization (Janke&Kunkel Ika-Werk Ultra Turrax). The homogenates were
centrifuged at 4000 rpm for 20 minutes. The supernatant was stored at - 20 °C. The stock-dilution of tissue was 1g/10ml
at  the  homogenization  which  was  1:5  diluted  individually  for  the  determination  of  tissue  hormone  concentrations.
Serum and tissue cortisol and testosterone concentrations were measured by ELISA (enzyme-linked immunosorbent
assay, DRG International, Marburg, Germany). The intra-assay variability (CV) of cortisol ELISA was 3.3%; the inter-
assay CV was 6.1%. The intra-assay CV of testosterone ELISA was 3.21%; the inter-assay CV was 4.74%.
The testes were halved, homogenized in a solution of 0.1 M trifluoroacetic acid, centrifuged and their dopamine
contents were measured by HPLC according to Rao et al [37]. The analysis of the samples was performed on a JASCO
HPLC  system  consisting  of  a  4180  analytical  pump,  a  4050  autosampler  unit  and  an  Antec  Decade  Elite
electrochemical  detector  (ABL&E-JASCO  Magyarország  Kft,  Budapest,  Hungary).  The  sample  components  were
separated using an isocratic method. The mobile phase was slightly modified from that of Rao et al [37] containing 6.8
g of sodium acetate, 5.9 g of citric acid, 48 mg of sodium ethylenediaminetetraacetate, 850 mg of octanesulfonic acid in
900 ml of water, at pH=3.6 and 100 ml of methanol. The stationary phase was a Recipe ClinRep analytical column for
catecholamines in the plasma, catalogue Nr. 2030 (Unicam Magyarország Kft, Budapest, Hungary) mounted with a
Phenomenex SecurityGuard™ C8 cartridge (Gen-Lab Kft, Budapest, Hungary). The flow rate was 0.9 mL/min and the
stationary phase was kept at 25 °C. 20 µL samples of aliquots were injected, kept at 5.0 °C during the analysis, and the
run time was 15 min. System control, data acquisition and evaluation were conducted employing the ChromNav 2.0
software (ABL&E-JASCO Magyarország Kft, Budapest, Hungary) and Microsoft Excel 2010.
3. RESULTS
Important characteristics of sperms show definite improvement in their progressive mobility (Table 1).
Table 1. Mass of testes, progressive motility of sperms, number of sperms and viability of sperms of control rats and that of
sperms of selegiline treated rats.
Rat (No.) Mass of Testes (g) Progressive Motility of Sperms (%) Number of Sperms (x106) in mL Viability (live/dead)
1 (control) 172 58.9 132 82
2 (control) 185 61.3 147 91
3 (control) 181 52.2 069 73
4 (control) 216 71.3 178 81
Mean 188.5±13.75 60.925±5.375 131.5±31.250 81.75±4.75
5 (treated) 179 78.6 143 92
6 (treated) 282 81.8 109 89
7 (treated) 199 79.5 209 96
8 (treated) 195 77.2 232 94
Mean 213.75± 79.275± 173.25± 92.75±
p = 0.180257 0.044423 0.728 0.172
The average mass of the testes, number of sperms and viability (live/dead sperms) were also increased relative to
these characteristics of rats in the control group. Cortisol content in the serum increased, while that in the adrenal gland
significantly decreased. Selegiline treatment definitely affected the testosterone level in the sera, the adrenal glands and
testes, whose levels decreased (Table 2).
Table 2. Cortisol and testosterone in serum, homogenate of adrenal glands and testes of control and selegiline treated rats.
Rat (No.) Cortisol Testosterone
Serum (nmol/L) In Homogenate Serum (nmol/L) In Homogenate
Adrenal Glands (ng/g) Testes (ng/g) Adrenal Glands (ng/g) Testes (ng/g)
1 (control) 27.078 247.992 59.079 4.48 1.155 74.469
2 (control) 121.629 501.210 42.755 8.786 0.788 54.162
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Rat (No.) Cortisol Testosterone
Serum (nmol/L) In Homogenate Serum (nmol/L) In Homogenate
Adrenal Glands (ng/g) Testes (ng/g) Adrenal Glands (ng/g) Testes (ng/g)
3 (control) 283.618 427.236 41.197 2.997 2.001 7.199
4 (control) 46.72 232.677 44.420 14.348 1.114 49.409
Mean 119.76±
82.86
352.28±
111.94
46.86±
6.10
7.65±
3.91
1.26±
0.3682
46.31±
1955
5 (treated) 166.944 248.552 43.940 1.879 0.870 16.927
6 (treated) 54.843 106.283 56.808 6.918 1.074 23.231
7 (treated) 142.744 476.313 47.804 4.255 1.206 23.768
8 (treated) 197.448 134.774 26.454 3.522 1.001 16.670
Mean 140.49±
42.82
241.48±
120.95
43.75±
8.64
4.14±
1.44
1.037±
0.1022
20.149±
3.3505
p = 0.3194 0.7081 0.4947 0.1794 0.0595 0.0084
HPLC analysis of the testes did not show any dopamine content over 5 pg/mg of tissue.
4. DISCUSSION
Hársing  and  Vizi  [38]  did  not  show  significantly  increased  dopamine  release  following  acute  treatment  of  rat
striatum using a therapeutic dose of selegiline. A four weeks’ (chronic) treatment [39] significantly increased both the
dopamine content and KCl facilitated dopamine release from rat striatal slices. Certain recent experiments have shown
that not only selegiline, but also p-fluorodeprenyl and rasagiline significantly improve the “quality” of sperms. Para-
fluorodeprenyl presents the most pronounced improving effect, while the effect of rasagiline proves to be the mildest.
Zieher  et  al  [34]  raised  the  question  why  the  concentrations  of  the  determined  biogenic  amines  (dopamine,
histamine, norepinephrine and serotonin) declined in the testes. However, no definite answer was given except that
Zieher et al [34] suggested that further experiment should be done.
CONCLUSION
Our results do not correspond to those of Urry et al [25, 26], and Wanichacheewa et al [40] as low testosterone
levels  and  sperm  concentrations  were  found  inversely  proportional.  To  describe  and  characterize  sperm  motility
Yanagimachi [41] and Bavister et al [42] used catecholamines (isoproterenol and norepinephirine) in vitro. Ramirez et
al [43] published the presence and function of dopamine D2 receptor in boar sperms, which is involved in the viability
and motility of sperms. The presence of 100 nM dopamine definitely increased sperm viability 1 hour through 4 hours,
as calculated by them from 10 parallel experiments using student t test.
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
Not applicable.
HUMAN AND ANIMAL RIGHTS
No Animals/Humans were used for studies that are base of this research.
CONSENT FOR PUBLICATION
Not applicable.
CONFLICT OF INTEREST
The authors declare no conflict of interest, financial or otherwise.
ACKNOWLEDGEMENTS
This  project  was  financially  supported  by  OTKA (Hungarian  National  Granting  Agency)  100155  grant  and  by
Kalász Research and Teaching Inc. (Budapest). Cooperation and advice by Ms. Györgyike Guth, Mr. János Horváth are
highly appreciated.
Kornélia Tekes and Huba Kalasz congratulate Dr. E.S. Vizi on his 81st birthday. Professor Vizi was our colleague at
the Department of Pharmacology, Semmelweis Medical University. We found him to be cooperative, with extensive
(Table ) contd.....
Selegiline - Favorable Effects on the Sperm’s Quality of Rats The Open Medicinal Chemistry Journal, 2017, Volume 11   143
knowledge on pharmacology and an excellent ability to perform experiments. . Prof. Vizi became the President of the
Hungarian Academy of Sciences, Budapest (2002-2008) and, even now, he continues his remarkable experiments and
publishes top-level papers.
REFERENCES
[1] Ecsery, Z.; Müller, M.; Knoll, J.; Somfai, É. Process to develop a new drug containing derivative of phenyl isopropylamine (in Hungarian).
Hungarian Patent, 151.090, 1962. March 30
[2] Ecsery, Z.; Kósa, I.; Knoll, J. Process to develop a new drug containing optically active derivative of phenylpropylamine (in Hungarian).
Hungarian Pat., 1965.
[3] Knoll, J.; Ecseri, Z.; Kelemen, K.; Nievel, J.; Knoll, B. Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.
Arch. Int. Pharmacodyn. Ther., 1965, 155(1), 154-164.
[PMID: 4378644]
[4] Knoll, J.; Magyar, K. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol., 1972, 5,
393-408.
[PMID: 5066229]
[5] Birkmayer, W.; Riederer, P.; Ambrozi, L.; Youdim, M.B. Implications of combined treatment with ‘Madopar’ and L-deprenil in Parkinson’s
disease. A long-term study. Lancet, 1977, 1(8009), 439-443.
[http://dx.doi.org/10.1016/S0140-6736(77)91940-7] [PMID: 65560]
[6] Miklya, I. The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015). Mol. Psychiatry, 2016, 21(11),
1499-1503.
[http://dx.doi.org/10.1038/mp.2016.127] [PMID: 27480491]
[7] Gordon, M.N.; Muller, C.D.; Sherman, K.A.; Morgan, D.G.; Azzaro, A.J.; Wecker, L. Oral versus transdermal selegiline: Antidepressant-like
activity in rats. Pharmacol. Biochem. Behav., 1999, 63(3), 501-506.
[http://dx.doi.org/10.1016/S0091-3057(99)00016-7] [PMID: 10418793]
[8] Bodkin,  J.A.;  Amsterdam,  J.D.  Transdermal  selegiline  in  major  depression:  A double-blind,  placebo-controlled,  parallel-group study in
outpatients. Am. J. Psychiatry, 2002, 159(11), 1869-1875.
[http://dx.doi.org/10.1176/appi.ajp.159.11.1869] [PMID: 12411221]
[9] Amsterdam,  J.D.  A  double-blind,  placebo-controlled  trial  of  the  safety  and  efficacy  of  selegiline  transdermal  system  without  dietary
restrictions in patients with major depressive disorder. J. Clin. Psychiatry, 2003, 64(2), 208-214.
[http://dx.doi.org/10.4088/JCP.v64n0216] [PMID: 12633131]
[10] Knoll, J. Sexual performance and longevity. Exp. Gerontol., 1997, 32(4-5), 539-552.
[http://dx.doi.org/10.1016/S0531-5565(96)00157-X] [PMID: 9315455]
[11] Knoll, J.; Miklya, I.; Knoll, B.; Dalló, J. Sexual hormones terminate in the rat: The significantly enhanced catecholaminergic/serotoninergic
tone in the brain characteristic to the post-weaning period. Life Sci., 2000, 67(7), 765-773.
[http://dx.doi.org/10.1016/S0024-3205(00)00671-8] [PMID: 10968406]
[12] Dalló, J. Receptivity of female rats. Acta Physiol. Acad. Sci. Hung., 1978, 51(3), 233-240.
[PMID: 573537]
[13] Dalló,  J.;  Held,  K.  Investigation of  copulative activity in male rats  in chronic experiment.  Acta Physiol.  Acad.  Sci.  Hung.,  1978,  51(3),
241-247.
[PMID: 755340]
[14] Dalló, J.; Held, K. Drugs and sexual behaviour in rats. Act. Nerv. Super. (Praha), 1972, 14(4), 303.
[PMID: 4263712]
[15] Yen, T.T.; Dalló, J.; Knoll, J. The aphrodisiac effect of low doses of (-) deprenyl in male rats. Pol. J. Pharmacol. Pharm., 1982, 34(5-6),
303-308.
[PMID: 6821215]
[16] Dalló, J.; Yen, T.T.; Knoll, J. The aphrodisiac effect of (-)deprenyl in male rats. Acta Physiol. Hung., 1990, (75Suppl), 75-76.
[17] Knoll,  J.;  Yen,  T.T.;  Dallo,  J.  Long-lasting,  true  aphrodisiac  effect  of  (-)-deprenyl  in  sexually  sluggish  old  male  rats.  Mod.  Probl.
Pharmacopsychiatry, 1983, 19, 135-153.
[http://dx.doi.org/10.1159/000407510] [PMID: 6408404]
[18] Dalló, J.; Lekka, N.; Knoll, J. The ejaculatory behavior of sexually sluggish male rats treated with (-)deprenyl, apomorphine, bromocriptine
and amphetamine. Pol. J. Pharmacol. Pharm., 1986, 38(3), 251-255.
[PMID: 3095802]
[19] Knoll, J. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron. J. Neural Trasm., 1987,
(25suppl), 45-66.
[20] Knoll, J.; Ecsery, Z.; Magyar, K.; Sátory, E. Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of
structure to their action. Biochem. Pharmacol., 1978, 27(13), 1739-1747.
144   The Open Medicinal Chemistry Journal, 2017, Volume 11 Kalász et al.
[http://dx.doi.org/10.1016/0006-2952(78)90550-6] [PMID: 708454]
[21] Knoll, J.; Dallo, J.; Yen, T.T. Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl. Life Sci., 1989, 45(6),
525-531.
[http://dx.doi.org/10.1016/0024-3205(89)90103-3] [PMID: 2505007]
[22] Dalló, J.; Knoll, J. Effect of (-)-para-fluoro-deprenyl on survival and copulation in male rats. Acta Physiol. Hung., 1992, 79(2), 125-129.
[PMID: 1304678]
[23] Knoll, J.; Yen, T.T.; Miklya, I. Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment
eliminates this difference. Life Sci., 1994, 54(15), 1047-1057.
[http://dx.doi.org/10.1016/0024-3205(94)00415-3] [PMID: 8152326]
[24] Dalló, J.; Köles, L. Longevity treatment with (-)deprenyl in female rats: Effect on copulatory activity and lifespan. Acta Physiol. Hung., 1996,
84(3), 277-278.
[PMID: 9219605]
[25] Urry, R.L.; Dougherty, K.A. Inhibition of rat spermatogenesis and seminiferous tubule growth after short-term and long-term administration
of a monoamine oxidase inhibitor. Fertil. Steril., 1975, 26(3), 232-239.
[http://dx.doi.org/10.1016/S0015-0282(16)40992-1] [PMID: 1116620]
[26] Urry,  R.L.;  Dougherty,  K.A.;  Cockett,  A.T.  Correlation  between follicle  stimulating  hormone,  luteinizing  hormone,  testosterone  and 5-
hydroxyindole acetic acid with sperm cell concentration. Trans. Am. Assoc. Genitourin. Surg., 1975, 67, 120-121.
[PMID: 1233801]
[27] Urry,  R.L.;  Dougherty,  K.A.;  Cockett,  A.T.  Age-related  changes  in  male  rat  reproductive  organ  weights  and  plasma  testosterone
concentrations  after  administration  of  a  monoamine  oxidase  inhibitor.  Fertil.  Steril.,  1976,  27(11),  1326-1334.
[http://dx.doi.org/10.1016/S0015-0282(16)42204-1] [PMID: 976507]
[28] Dougherty, K.A.; Cockett, A.T.; Urry, R.L. Caffeine, theophylline, and human sperm motility. Fertil. Steril., 1976, 27(5), 541-548.
[http://dx.doi.org/10.1016/S0015-0282(16)41836-4] [PMID: 819309]
[29] Mihalik, J.; Mašlanková, J.; Solár, P.; Horváthová, F.; Hubková, B.; Almášiová, V.; Šoltés, J.; Švaňa, M.; Rybárová, S.; Hodorová, I. The
effect of R-(-)-deprenyl administration on reproductive parameters of rat males. Eur. J. Pharmacol., 2015, 754, 148-152.
[http://dx.doi.org/10.1016/j.ejphar.2015.02.030] [PMID: 25725114]
[30] Horváthová,  F.;  Danielisová,  V.;  Domoráková,  I.;  Solár,  P.;  Rybárová,  S.;  Hodorová,  I.;  Mihalik,  J.  The  effect  of  R-(-)-deprenyl
administration  on  antioxidant  enzymes  in  rat  testis.  Eur.  J.  Pharmacol.,  2016,  788,  21-28.
[http://dx.doi.org/10.1016/j.ejphar.2016.06.015] [PMID: 27292162]
[31] Lalkovicova,  M.;  Horvathova,  F.;  Sulla,  I.;  Mihalik,  J.;  Danielisova,  V.  Effects  of  low  and  high  deprenyl  dose  on  antioxidant  enzyme
activities in the adult rat brain. Gen. Physiol. Biophys., 2017, 36(1), 83-90.
[http://dx.doi.org/10.4149/gpb_2016023] [PMID: 27901472]
[32] Tekes, K.; Pöstényi, Z.; Faigl, E.B.; Magyar, K.; Polyák, A.; Trencsényi, G.; Balogh, L.; Kalász, H. Distribution of N-methyl-(14)C-labeled
selegiline in the rat. J. Pharm. Biomed. Anal., 2015, 111, 147-152.
[http://dx.doi.org/10.1016/j.jpba.2015.03.022] [PMID: 25886391]
[33] Kalász, H.; Tekes, K.; Pöstényi, Z.; Vizvári, E.; Sotonyi, P.; Szabó, D.; Tóth-Molnár, E. Pharmacokinetics of selegiline in a rabbit model.
Lett. Drug Des. Discov., 2016, 13, 752-756.
[http://dx.doi.org/10.2174/1570180813666160125224604]
[34] Zieher, L.M.; Debeljuk, L.; Iturriza, F.; Mancini, R.E. Biogenic amine concentration in testes of rats at different ages. Endocrinology, 1971,
88(2), 351-354.
[http://dx.doi.org/10.1210/endo-88-2-351] [PMID: 5540049]
[35] Carlsson,  A.;  Waldeck,  B.  A fluorimetric  method  for  the  determination  of  dopamine  (3-hydroxytyramine).  Acta  Physiol.  Scand.,  1958,
44(3-4), 293-298.
[http://dx.doi.org/10.1111/j.1748-1716.1958.tb01628.x] [PMID: 13617024]
[36] Bearden, H.J.; Fuquay, J.W. Applied Animal Reproduction, 5th ed; Pearson Press: New York, NY, 2000.
[37] Rao,  P.S.;  Rujikarn,  N.;  Luber,  J.M.;  Tyras,  D.H.  A  specific  sensitive  HPLC  method  for  determination  of  plasma  dopamine.
Chromatographia,  1989,  28,  307-310.
[http://dx.doi.org/10.1007/BF02260781]
[38] Hársing,  L.G.,  Jr;  Vizi,  E.S.  Release  of  endogenous  dopamine  from  rat  isolated  striatum:  Effect  of  clorgyline  and  (-)-deprenyl.  Br.  J.
Pharmacol., 1984, 83(3), 741-749.
[http://dx.doi.org/10.1111/j.1476-5381.1984.tb16228.x] [PMID: 6439273]
[39] Kalász, H.; Kerecsen, L.; Knoll, J.; Pucsok, J. Chromatographic studies on the binding, action and metabolism of (-)-deprenyl. J. Chromatogr.
A, 1990, 499, 589-599.
[http://dx.doi.org/10.1016/S0021-9673(00)97003-1] [PMID: 2108980]
[40] Wanichacheewa, S.; Singtripop, T.; Sassa, S.; Sakamoto, S.; Mori, T. Decrease in the number of sperm associated with decreased blood
testosterone  levels  in  male  rats  treated  with  extracts  from  seven  plants  consumed  by  natives  of  northern  Thailand.  Environ.  Toxicol.
Pharmacol., 2001, 10(1-2), 1-4.
Selegiline - Favorable Effects on the Sperm’s Quality of Rats The Open Medicinal Chemistry Journal, 2017, Volume 11   145
[http://dx.doi.org/10.1016/S1382-6689(00)00071-5] [PMID: 11382551]
[41] Yanagimachi, R. in vitro capacitation of hamster spermatozoa by follicular fluid. J. Reprod. Fertil., 1969, 18(2), 275-286.
[http://dx.doi.org/10.1530/jrf.0.0180275] [PMID: 5815307]
[42] Bavister, B.D.; Chen, A.F.; Fu, P.C. Catecholamine requirement for hamster sperm motility in vitro. J. Reprod. Fertil., 1979, 56(2), 507-513.
[http://dx.doi.org/10.1530/jrf.0.0560507] [PMID: 480308]
[43] Ramírez, A.R.; Castro, M.A.; Angulo, C.; Ramió, L.; Rivera, M.M.; Torres, M.; Rigau, T.; Rodríguez-Gil, J.E.; Concha, I.I. The presence and
function of  dopamine type 2  receptors  in  boar  sperm:  A possible  role  for  dopamine in  viability,  capacitation,  and modulation of  sperm
motility. Biol. Reprod., 2009, 80(4), 753-761.
[http://dx.doi.org/10.1095/biolreprod.108.070961] [PMID: 19074002]
© 2017 Kalász et al.
This is an open access article distributed under the terms of the Creative Commons Attribution 4. 0 International Public License (CC-BY 4. 0), a
copy of which is available at: https://creativecommons. org/licenses/by/4. 0/legalcode. This license permits unrestricted use, distribution, and
reproduction in any medium, provided the original author and source are credited.
